Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$0.32 - $0.79 $31,299 - $77,269
-97,810 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$0.72 - $1.11 $70,423 - $108,569
97,810 New
97,810 $73,000

Others Institutions Holding OPGN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About OPGEN INC


  • Ticker OPGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,698,500
  • Market Cap $38.7M
  • Description
  • OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...
More about OPGN
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.